Does Blue Cross Cover Zepbound? Dropped Plans, Denials, Appeals

In 2026, most Blue Cross Blue Shield plans do not cover Zepbound for weight loss. Whether your specific plan does depends on three things: the BCBS affiliate that runs it, whether it is fully insured or self-funded, and whether your employer paid extra for GLP-1 coverage. A separate FDA-approved use of Zepbound for obstructive sleep apnea opens a narrow coverage path on some plans even where weight-loss coverage has been dropped.

Zepbound is Eli Lilly’s brand name for tirzepatide. The FDA approved it in November 2023 for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition such as hypertension, sleep apnea, or type 2 diabetes.1U.S. Food and Drug Administration. FDA Approves New Medication for Chronic Weight Management It later received an FDA indication for moderate-to-severe obstructive sleep apnea in adults with obesity.2U.S. Food and Drug Administration. Zepbound Prescribing Information

BCBS Plans That Have Dropped Zepbound

Several of the largest BCBS affiliates have excluded Zepbound and other weight-loss GLP-1s heading into 2026, citing drug spending that doubled or close to it year over year.

Massachusetts. BCBS of Massachusetts excluded Zepbound, Wegovy, and Saxenda from all fully insured group and individual commercial plans at each plan’s 2026 renewal date.3Blue Cross Blue Shield of Massachusetts. GLP-1 Coverage Update The insurer said five GLP-1 drug companies accounted for 20 percent of its 2024 pharmacy spend, more than $300 million, double the prior year.4CBS News Boston. Blue Cross Blue Shield Massachusetts Weight Loss GLP-1 It is a benefit exclusion, which means it cannot be appealed on medical necessity grounds. Employer groups larger than 100 employees can buy a rider that restores coverage; smaller groups cannot.5Blue Cross Blue Shield of Massachusetts. GLP-1 FAQs for Accounts and Brokers

Michigan. BCBS of Michigan ended coverage of all GLP-1 weight-loss drugs for fully insured large-group commercial members on January 1, 2025. The state’s Director of Insurance upheld the denial in an August 2025 administrative ruling.6Michigan Department of Insurance and Financial Services. BCBSM File No. 238501-001, Final Determination BCBS Michigan goes further than most peers: under the evaluated plans it does not cover Zepbound for any condition, including obstructive sleep apnea.7Michigan Department of Insurance and Financial Services. BCBSM File No. 236103-001, Final Determination

North Dakota. BCBS of North Dakota pulled weight-loss drug coverage from fully insured non-grandfathered large-group plans on January 1, 2026, after a 46 percent jump in GLP-1 spending during 2025 and projected costs reaching $23 million.8BCBS North Dakota. 2026 Weight Loss Drug Changes Small-group and individual (metallic) plans keep the coverage because the state added GLP-1s to its Essential Health Benefit benchmark.9BCBS North Dakota. Updates to 2026 Weight Loss Medication Coverage

California. Blue Shield of California restricted Zepbound starting January 1, 2025. Commercial PPO and HMO members can get it only through prior authorization showing a current or previous Class III (morbid) obesity diagnosis, with participation in a comprehensive weight-loss program.10Blue Shield of California. Weight Loss Drug Exclusion Fact Sheet

Texas. BCBS of Texas is mixed. As of May 2026, the Zepbound KwikPen is excluded and only available through direct-to-consumer channels, while the Zepbound auto-injection formulation stays on drug lists for employer groups that elected GLP-1 weight-management coverage.11BCBS Texas. New GLP-1 Coverage 2026

Where Zepbound Is Still Covered

Coverage has not disappeared everywhere. A few BCBS situations still pay for Zepbound.

FEP Blue (federal employees). The Federal Employee Program covers Zepbound for chronic weight management under policy 5.99.031, effective January 1, 2026, as a non-preferred option with prior authorization.12CVS Caremark / FEP. FEP Criteria: Zepbound Approval requires that you have tried and failed at least two oral weight-management medications, are participating in a comprehensive weight-management program, and are not on another GLP-1. Initial approval runs six months for up to 12 single-dose pens per 84 days; renewal requires at least 5 percent documented weight loss from baseline. Note the boundary: FEP Basic and Standard options cover Wegovy, not Zepbound.13Government Executive. More GLP-1 Options for Federal Retirees

Self-funded employer plans. When the employer bears the financial risk and BCBS only administers the plan, the employer decides whether weight-loss drugs are covered. BCBS affiliates in North Dakota and Texas have explicitly flagged that self-funded clients may opt into GLP-1 coverage.9BCBS North Dakota. Updates to 2026 Weight Loss Medication Coverage If you are on a self-funded plan, the real decision maker is your HR benefits team, not BCBS.

State-mandated plans. North Dakota’s small-group and individual (metallic) plans continue coverage because the state in January 2025 became the first to add GLP-1s to its Essential Health Benefit benchmark.14Pharmacy Times. States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments

The Sleep Apnea Pathway

Zepbound’s second FDA indication, moderate-to-severe obstructive sleep apnea in adults with obesity, matters for coverage.2U.S. Food and Drug Administration. Zepbound Prescribing Information Some BCBS plans will pay for Zepbound under the OSA indication even if they exclude it for weight loss. BlueCross Healthy Blue in South Carolina, for example, covers it for OSA with prior authorization when a sleep study documents at least 15 obstructive respiratory events per hour, BMI is 30 or higher, and the patient is engaged in diet and exercise. Initial approval runs six months, with 12-month renewals contingent on clinical response.15South Carolina Blues. Zepbound (Tirzepatide) for Obstructive Sleep Apnea

This is not universal. BCBS Michigan refuses to cover Zepbound for OSA under its evaluated plans.7Michigan Department of Insurance and Financial Services. BCBSM File No. 236103-001, Final Determination Check your specific plan’s medical policy before assuming an OSA diagnosis will unlock coverage.

Prior Authorization When Coverage Exists

Plans that do cover Zepbound apply strict prior authorization. The usual elements are a current obesity diagnosis, BMI documentation, participation in a reduced-calorie diet and physical activity, documentation of previously tried and failed medications, and absence of contraindications such as a history of gastroparesis or medullary thyroid carcinoma. Renewal typically requires at least 5 percent weight loss from baseline. BCBS Texas Medicaid applies that framework.16BCBS Texas. Zepbound Prior Authorization Form FEP requires failure of two oral weight-management medications and enrollment in a comprehensive weight-management program such as Teladoc.12CVS Caremark / FEP. FEP Criteria: Zepbound Before it dropped the drug, BCBS Michigan required a BMI of 35 or higher, six months of documented lifestyle modification with actual records rather than attestations, and Teladoc coaching enrollment.17BCBS Michigan. Changes to Weight Loss Drugs, Commercial Plans

What To Do If You Are Denied

The right next step depends on the kind of denial. A formulary exclusion, where weight-loss drugs are simply not a covered benefit, generally cannot be reversed through appeal. BCBS Massachusetts has stated its exclusion cannot be appealed on medical necessity.3Blue Cross Blue Shield of Massachusetts. GLP-1 Coverage Update

When the denial is based on medical necessity, prior authorization, or step therapy, you typically have 180 days to file an internal appeal. The insurer must respond within 30 to 60 days, or 72 hours for urgent cases. If the internal appeal fails, you can request an independent external review, which is free and binding on the insurer. A strong appeal file includes a letter of medical necessity from the prescriber with ICD-10 codes, BMI history, documentation of failed prior treatments, and lifestyle modification records. You can also request a peer-to-peer call between the prescribing doctor and the insurer’s medical director.

If your plan excludes weight loss but covers OSA, ask whether the prescription can be written to the sleep apnea diagnosis instead. Plan terms vary, and some plans will pay on the OSA indication where they will not pay on the obesity indication.

Paying for Zepbound Without Coverage

If your BCBS plan does not pay, Eli Lilly offers two routes to reduce the price. Members with commercial insurance that does not cover Zepbound can use the Lilly savings card to pay as low as $499 per month for the single-dose pen.18Eli Lilly. Zepbound Savings Patients paying entirely out of pocket can buy single-dose vials through LillyDirect at $299 per month for the lowest dose and $449 per month for doses of 7.5 mg and above, provided refills are completed within 45 days.19CNBC. Eli Lilly Prices Zepbound Weight Loss Drug Vials Vials require you to draw the medication with a syringe. All Lilly savings programs expire December 31, 2026, and patients in Medicare, Medicaid, TRICARE, or other government programs are ineligible.

HSA and FSA accounts can be used to pay for Zepbound even when insurance will not.5Blue Cross Blue Shield of Massachusetts. GLP-1 FAQs for Accounts and Brokers For comparison, Zepbound’s list price runs about $1,087 per month.19CNBC. Eli Lilly Prices Zepbound Weight Loss Drug Vials

Medicare Members and the GLP-1 Bridge

Medicare has been barred by law from covering drugs prescribed solely for weight loss. That is partly changing. The Medicare GLP-1 Bridge program launches July 1, 2026, and runs through at least December 2027.20STAT News. Medicare Weight Loss Drugs GLP-1 Bridge Program It covers Zepbound (KwikPen formulation only) and Wegovy at a $50 copay per prescription, and that copay does not count toward the Part D out-of-pocket maximum.21Centers for Medicare and Medicaid Services. Medicare GLP-1 Bridge

You must be enrolled in a standalone Part D plan or a Medicare Advantage plan with drug coverage. The prescriber submits prior authorization to a central processor run by Humana attesting that you are 18 or older and meet BMI thresholds: 35 or higher; or 30 or higher with conditions like heart failure, uncontrolled hypertension, or chronic kidney disease; or 27 or higher with pre-diabetes or a history of heart attack, stroke, or peripheral artery disease.22Centers for Medicare and Medicaid Services. Medicare GLP-1 Bridge Information for Providers For BCBS members on Medicare Advantage, this is the first realistic covered pathway.

State Laws That Could Change This

A handful of states have moved on anti-obesity drug mandates that could eventually bind BCBS affiliates.

Until more mandates take effect, whether Blue Cross covers Zepbound comes down to your specific plan documents. Start by pulling your 2026 Summary of Benefits and prescription drug formulary, confirm whether your plan is fully insured or self-funded, and if coverage is excluded, ask HR whether a GLP-1 rider is available at your next renewal.